Sponsors that wish to develop a therapeutic often rely on the Clinilabs’ Medical and Scientific Affairs group for assistance in the development of clinical trial protocols. Protocols developed by Clinilabs are based on industry standards, and tailored to the specific characteristics of the drug under study. The objective of our team is to deliver protocols that provide sound empirical tests of drug efficacy and safety.
Clinilabs works directly with the sponsor, key opinion leaders, and scientific writers to develop protocols that swiftly move from concept to completion. Our team also helps ensure that regulatory documents are prepared in a timely way, so that studies can start without delay.
|
